Taking tuberculosis preventive therapy implementation to national scale: the Nigerian PEPFAR Program experience.

Odume, B; Meribe, S C; Odusote, T; Ifunanya, M; Debem, H; Amazue-Ezeuko, I; Ogbanufe, O; Adamu, Y; Onotu, D

Odume, B; Meribe, S C; Odusote, T; Ifunanya, M; Debem, H; Amazue-Ezeuko, I; Ogbanufe, O; Adamu, Y; Onotu, D.

Afiliación

Odume B; Division of Global HIV/AIDS and TB, United States (US) Centers for Disease Control and Prevention, Abuja, Nigeria.
Meribe SC; US Army Medical Research Directorate-Africa/Nigeria, Abuja, Nigeria.
Odusote T; US Agency for International Development (USAID), Abuja, Nigeria.
Ifunanya M; Division of Global HIV/AIDS and TB, United States (US) Centers for Disease Control and Prevention, Abuja, Nigeria.
Debem H; Division of Global HIV/AIDS and TB, United States (US) Centers for Disease Control and Prevention, Abuja, Nigeria.
Amazue-Ezeuko I; US Army Medical Research Directorate-Africa/Nigeria, Abuja, Nigeria.
Ogbanufe O; Henry Jackson Foundation for Medical Research International, Abuja, Nigeria BO and SCM contributed equally to this manuscript.
Adamu Y; Division of Global HIV/AIDS and TB, United States (US) Centers for Disease Control and Prevention, Abuja, Nigeria.
Onotu D; US Army Medical Research Directorate-Africa/Nigeria, Abuja, Nigeria.

Public Health Action ; 10(1): 7-10, 2020 Mar 21.

Article en En | MEDLINE | ID: mdl-32368517

Palabras clave

TB preventive therapy; human immunodeficiency virus; isoniazid preventive therapy; people living with HIV; tuberculosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Sysrev_observational_studies Aspecto: Implementation_research Idioma: En Revista: Public Health Action Año: 2020 Tipo del documento: Article País de afiliación: Nigeria Pais de publicación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google